19 Optimizing oncologic outcomes in high-grade non-muscle invasive bladder cancer: Theimpact of a surgeon-led treatment pathway

19 Optimizing oncologic outcomes in high-grade non-muscle invasive bladder cancer: Theimpact of a surgeon-led treatment pathway

Saved in:

Bibliographic Details
Main Authors:	P. Scilipoti, G. Rosiello, A. Viti, A. Santangelo, A. Briganti, M. Moschini, F. Montorsi
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168325000229
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy
by: Hege S. Haugnes, et al.
Published: (2025-01-01)

Metastasis to Sartorius Muscle from a Muscle Invasive Bladder Cancer
by: Ioannis Katafigiotis, et al.
Published: (2014-01-01)

Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer
by: A. V. Troianov, et al.
Published: (2023-03-01)

Current capabilities of endoscopic diagnosis of non-muscle invasive bladder cancer
by: I. N. Zaborskii, et al.
Published: (2020-06-01)

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer
by: Harry W. Herr
Published: (2011-01-01)

The Clinical Impact of Tumor Grade Heterogeneity in Nonmuscle- invasive Urothelial Carcinoma of the Bladder
by: Meftun Culpan, et al.
Published: (2021-12-01)

The Role of the Surgeon and Transurethral Resection in the Treatment of Superficial Bladder Cancer
by: Alan M. Nieder, et al.
Published: (2006-01-01)

Conservative Management of Muscle Invasive Bladder Cancer in Kidney-Pancreas Transplant Patient
by: Logan D. Glosser, et al.
Published: (2022-01-01)

Impact of HER2 Expression on the Prognosis of Muscle-Invasive Bladder Cancer Patients Treated with Bladder-Preservation Comprehensive Therapy
by: Yatong Chen, et al.
Published: (2025-01-01)

The prognostic effect of immunohistochemical staining rates in patients with non–muscle-invasive bladder cancer
by: Aykut Demirci, et al.
Published: (2023-07-01)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
by: Liam Mannion, et al.
Published: (2024-11-01)

Prognostic evaluation of non-muscle invasive bladder cancer with P-CRP and its nomogram
by: Junyun Wu, et al.
Published: (2025-02-01)

Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy
by: A. Contreras-Sanz, et al.
Published: (2025-02-01)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
by: Kira Furlano, et al.
Published: (2024-11-01)

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
by: J Alfred Witjes, et al.
Published: (2023-01-01)

Cystatin C as a predictor of acute renal damage after radical surgical treatment in patients with muscle-invasive bladder cancer
by: A. I. Tarasenko, et al.
Published: (2021-06-01)

Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer
by: Ekamjit S. Deol, et al.
Published: (2024-11-01)

AI predicting recurrence in non-muscle-invasive bladder cancer: systematic review with study strengths and weaknesses
by: Saram Abbas, et al.
Published: (2025-01-01)

Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study
by: Takashi Kawahara, et al.
Published: (2025-01-01)

Clinicopathological study and molecular subtyping of muscle-invasive bladder cancer (MIBC) using dual immunohistochemical (IHC) markers
by: R. Vaithegi, et al.
Published: (2025-01-01)

21 FBXW7 loss-of-function is associated with worse overall survival and leads to the accumulation of MYC in muscle-invasive bladder cancer
by: P. Black, et al.
Published: (2025-01-01)

Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
by: Ursula Lemberger, et al.
Published: (2025-01-01)

The Use of Regenerative Medicine in the Management of Invasive Bladder Cancer
by: Matthew E. Hyndman, et al.
Published: (2012-01-01)

Robotic Surgery from a Gynaecological Oncology Perspective: A Global Gynaecological Oncology Surgical Outcomes Collaborative Led Study (GO SOAR3)
by: Faiza Gaba, et al.
Published: (2025-01-01)

Sex-specific differences in recurrence and progression following cytostatic intravesical chemotherapy for non-muscle invasive urothelial bladder cancer (NMIBC)
by: Laila Schneidewind, et al.
Published: (2025-02-01)

Predicting recurrence of non-muscle invasive bladder urothelial carcinoma: predictive value of the optimal cut-off value of Ki67
by: Rende Peng, et al.
Published: (2025-01-01)

Risk factors for lymphatic leakage following radical cystectomy and pelvic lymph node dissection in patients with muscle-invasive bladder cancer
by: Zixuan Xue, et al.
Published: (2025-01-01)

AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer
by: Pierre-Antoine Bannier, et al.
Published: (2024-12-01)

Optimal Treatment for Intermediate- and High-Risk, Nonmuscle-Invasive Bladder Cancer
by: A.P.M. van der Meijden
Published: (2006-01-01)

Bladder-sparing therapy in a case report of huge muscle-invasive bladder IMT treated with 1470 nm diode laser en bloc resection followed by laparoscopic partial cystectomy
by: Junhao Chu, et al.
Published: (2025-02-01)

The usage of the paris classification system in urine cytology in the diagnosis of non-muscle-invasive bladder cancer: a retrospective single-center study
by: Perttu Saarinen, et al.
Published: (2025-01-01)

Delayed Local Recurrence Following Radiation Therapy for Muscle-Invasive Bladder Cancer Emphasizing the Need for Lifelong Surveillance: a Case Report
by: Rajitha Sunkara, et al.
Published: (2008-01-01)

Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
by: Franklin C. Lee, et al.
Published: (2013-01-01)

Diffusion-weighted MRI-Derived ADC and tumor volume as predictive imaging markers for neoadjuvant chemotherapy response in muscle-invasive bladder cancer
by: Abolfazl Razzaghdoust, et al.
Published: (2025-01-01)

FROM ONCOLOGIST TO SURGEON - GENETICS IN COLORECTAL METASTASIS FOR SURGEONS
by: Marília Polo Mingueti e SILVA, et al.
Published: (2025-02-01)

Hybrid discrete-continuous model of invasive bladder cancer
by: Eugene Kashdan, et al.
Published: (2013-03-01)

Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer
by: Franklin D. Gaylis, et al.
Published: (2024-10-01)

Indian consensus statements on the management of small renal masses, non‐muscle invasive bladder cancer and high‐risk/locally advanced prostate cancer
by: Simon Hughes, et al.
Published: (2024-11-01)

A Case of Giant Bladder Carcinosarcoma without Submucosal Invasion
by: Masayoshi Zaitsu, et al.
Published: (2011-01-01)

New horizons of Flaubert: from a barber-surgeon to a modern trauma surgeon
by: Kun Hwang
Published: (2022-08-01)